000			01976 a2200541 4500
005			20250514005419.0
264		0	_c20010830
008			200108s 0 0 eng d
022			_a1524-4571
024	7		_a10.1161/hh1601.094983 _2doi
040			_aNLM _beng _cNLM
100	1		_aWedgwood, S
245	0	0	_aRole for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. _h[electronic resource]
260			_bCirculation research _cAug 2001
300			_a357-64 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdministration, Inhalation
650	0	4	_aAnimals
650	0	4	_aBlotting, Western
650	0	4	_aCells, Cultured
650	0	4	_aDioxoles _xpharmacology
650	0	4	_aDisease Models, Animal
650	0	4	_aEndothelin Receptor Antagonists
650	0	4	_aEndothelin-1 _xmetabolism
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aHumans
650	0	4	_aHypertension, Pulmonary _xchemically induced
650	0	4	_aLung _xchemistry
650	0	4	_aMicroscopy, Fluorescence
650	0	4	_aMuscle, Smooth, Vascular _xcytology
650	0	4	_aNitrates _xchemistry
650	0	4	_aNitric Oxide _xadministration & dosage
650	0	4	_aNitric Oxide Donors _xpharmacology
650	0	4	_aNitric Oxide Synthase _xchemistry
650	0	4	_aNitric Oxide Synthase Type III
650	0	4	_aPulmonary Artery _xcytology
650	0	4	_aReceptor, Endothelin A
650	0	4	_aSecondary Prevention
650	0	4	_aSheep
650	0	4	_aSuperoxides _xmetabolism
650	0	4	_aTyrosine _xanalogs & derivatives
700	1		_aMcMullan, D M
700	1		_aBekker, J M
700	1		_aFineman, J R
700	1		_aBlack, S M
773	0		_tCirculation research _gvol. 89 _gno. 4 _gp. 357-64
856	4	0	_uhttps://doi.org/10.1161/hh1601.094983 _zAvailable from publisher's website
999			_c11434178 _d11434178